var data={"title":"Abdominal tuberculosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Abdominal tuberculosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/contributors\" class=\"contributor contributor_credentials\">Vineet Ahuja, MD, DM</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/contributors\" class=\"contributor contributor_credentials\">Sanjiv Chopra, MD, MACP</a></dd><dd><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/contributors\" class=\"contributor contributor_credentials\">C Fordham von Reyn, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 29, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abdominal tuberculosis (TB) includes involvement of the gastrointestinal tract, peritoneum, lymph nodes, <span class=\"nowrap\">and/or</span> solid organs [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1-4\" class=\"abstract_t\">1-4</a>]. Abdominal TB comprises around 5 percent of all cases of TB [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Issues related to TB involving the intestinal tract, peritoneum, and liver will be reviewed here; issues related to clinical manifestations, diagnosis, and treatment of pulmonary TB are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-complications-of-pulmonary-tuberculosis\" class=\"medical medical_review\">&quot;Clinical manifestations and complications of pulmonary tuberculosis&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">&quot;Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2572768201\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Risk factors for development of abdominal TB include cirrhosis, HIV infection, diabetes mellitus, underlying malignancy, treatment with anti-tumor necrosis factor (TNF) agents, and use of peritoneal dialysis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/6-10\" class=\"abstract_t\">6-10</a>]. Issues related to the epidemiology of TB are discussed further separately. (See <a href=\"topic.htm?path=epidemiology-of-tuberculosis\" class=\"medical medical_review\">&quot;Epidemiology of tuberculosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4048459905\"><span class=\"h1\">FORMS OF DISEASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abdominal TB can present with involvement of any of the following sites: peritoneum, esophagus, stomach, intestinal tract, hepatobiliary tree, pancreas, perianal area, and lymph nodes. The most common forms of disease include involvement of the peritoneum, intestine, <span class=\"nowrap\">and/or</span> liver.</p><p>Tuberculosis of the abdomen may occur via reactivation of latent TB infection or by ingestion of tuberculous mycobacteria (as with ingestion of unpasteurized milk or undercooked meat). In the setting of active pulmonary TB or miliary TB, abdominal involvement may develop via hematogenous spread via contiguous spread of TB from adjacent organs (such as retrograde spread from the fallopian tubes) or via spread through lymphatic channels [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>In general, clinical manifestations of abdominal TB depend on the form of disease and may include fever, weight loss, abdominal pain <span class=\"nowrap\">and/or</span> distension, ascites, hepatomegaly, diarrhea, and abdominal mass [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/11\" class=\"abstract_t\">11</a>]. Additional issues related to clinical manifestations are discussed in the following sections.</p><p>Routine laboratory tests demonstrate mild anemia and increased sedimentation rate in 50 to 80 percent of patients; the white blood count is usually normal [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/12\" class=\"abstract_t\">12</a>]. Approximately 15 to 25 percent of patients with abdominal TB have concomitant pulmonary TB [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H2513640203\"><span class=\"h2\">Peritoneal tuberculosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Peritoneal TB occurs most commonly following reactivation of latent tuberculous foci in the peritoneum established via hematogenous spread from a primary lung focus [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/6\" class=\"abstract_t\">6</a>]. TB peritonitis can also occur via hematogenous spread in the setting of active pulmonary TB or miliary TB. Much less commonly, tuberculous mycobacteria enter the peritoneal cavity transmurally from an infected small intestine or via contiguous spread from tuberculous salpingitis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/13\" class=\"abstract_t\">13</a>]. As the disease progresses, the visceral and parietal peritoneum become studded with tubercles. Ascites develop secondary to exudation of proteinaceous fluid from the tubercles.</p><p>Clinical manifestations of peritoneal TB include ascites (93 percent), abdominal pain (73 percent), and fever (58 percent) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/10\" class=\"abstract_t\">10</a>]. Typically, symptoms have persisted for week or months before the diagnosis is established [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/14-16\" class=\"abstract_t\">14-16</a>]. More than 90 percent of patients with tuberculous peritonitis have ascites at the time of presentation, with a serum-ascites albumin gradient (SAAG) &lt;1.1 <span class=\"nowrap\">g/dL</span> (in the absence of cirrhosis) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/17\" class=\"abstract_t\">17</a>]. In 10 percent of cases, patients present with a more advanced &quot;dry&quot; phase with a &quot;doughy&quot; abdomen, which represents a fibroadhesive form of the disease [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/18,19\" class=\"abstract_t\">18,19</a>]. The absence of signs of chronic liver disease (such as palmar erythema, spider angiomata, and dilated abdominal wall veins) should increase clinical suspicion for TB peritonitis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"topic.htm?path=evaluation-of-adults-with-ascites#H64022813\" class=\"medical medical_review\">&quot;Evaluation of adults with ascites&quot;, section on 'Serum-to-ascites albumin gradient'</a>.)</p><p>In patients with renal failure on continuous ambulatory peritoneal dialysis (CAPD), clinical manifestations of tuberculous peritonitis typically develop within the first year of beginning CAPD and are usually indistinguishable from bacterial peritonitis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis&quot;</a>.)</p><p>In one series including 60 patients, risk factors for tuberculous peritonitis included (in descending order of frequency): cirrhosis, CAPD, diabetes mellitus, underlying malignancy, use of systemic corticosteroids, and AIDS [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/10\" class=\"abstract_t\">10</a>]. No risk factor was identified in 20 percent of cases. The mean age at presentation was 55 with an approximately equal gender distribution.</p><p class=\"headingAnchor\" id=\"H3439164440\"><span class=\"h2\">Intestinal tuberculosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Signs and symptoms in a patient with intestinal tuberculosis may include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical manifestations reflecting intestinal ulcero-constrictive disease; these include intestinal colic, abdominal distension, chronic diarrhea, nausea, vomiting, constipation, and bleeding.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical manifestations reflecting adjacent tissue involvement; these include ascites, lymph node enlargement, and tubo-ovarian symptoms.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical manifestations of chronic inflammation; these include fever, fatigue, weight loss, and night sweats.</p><p/><p>The symptoms depend upon the site(s) of involvement and the type of lesions. Abdominal pain is the most common manifestation and can occur because of a stricture of the intestinal lumen, mesenteric inflammation, <span class=\"nowrap\">and/or</span> peritoneal involvement. Diarrhea occurs in 11 to 37 percent of patients and may reflect small <span class=\"nowrap\">and/or</span> large intestinal involvement. Lower gastrointestinal bleeding occurs in 5 to 15 percent of patients with intestinal tuberculosis; the bleeding is rarely massive. Constipation occurs in near half of patients with intestinal tuberculosis. Constitutional symptoms (fever, malaise, night sweats, anorexia, and weight loss) are common in patients with intestinal TB [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/20-23\" class=\"abstract_t\">20-23</a>]. A palpable right lower quadrant abdominal mass is present in 25 to 50 percent of patients [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/24,25\" class=\"abstract_t\">24,25</a>]. Fistula and intestinal stricture may occur. Bowel obstruction is the most common complication and may be due to progressive stricture or adhesions [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/26-28\" class=\"abstract_t\">26-28</a>].</p><p>Multiple areas of the bowel can be affected. The ileocecal region is the most common site of intestinal involvement; it is affected in 75 percent of cases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"abstract_t\">1</a>]. The affinity of <em>Mycobacterium tuberculosis</em> for this site may be due to the relative stasis and abundance of lymphoid tissue in this region. The organism penetrates the mucosa and localizes in the submucosal lymphoid tissue, where it initiates an inflammatory reaction with subsequent lymphangitis, endarteritis, granuloma formation, caseation necrosis, mucosal ulceration, and scarring. Other locations of involvement, in order of descending frequency, are the ascending colon, jejunum, appendix, duodenum, stomach, esophagus, sigmoid, colon and rectum [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The epidemiology of tuberculous enteritis varies widely; young adults, primarily women, are mostly affected in regions like Pakistan, Turkey, and West Africa, whereas a lower disease incidence but similar or greater numbers of male patients are reported in studies from China, Singapore, India, and the United Kingdom [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p class=\"headingAnchor\" id=\"H631605469\"><span class=\"h2\">Hepatic tuberculosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are two presentations of hepatic TB: miliary hepatic disease and local hepatic disease. Liver involvement in miliary TB occurs in approximately 80 percent of cases of disseminated tuberculosis; in this form, TB reaches the liver via the hepatic artery. Local hepatic TB occurs in approximately 20 percent of cases; in this form, TB reaches the liver from the intestinal tract via the portal vein or gastrointestinal lymphatics or may represent reactivation of latent tuberculosis infection.</p><p>The most common signs and symptoms of hepatic TB include hepatomegaly (80 percent), fever (67 percent), respiratory symptoms (66 percent), abdominal pain (60 percent), and weight loss (58 percent); other signs include splenomegaly (30 percent), ascites (20 percent), and jaundice (20 percent) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"abstract_t\">30</a>]. Local hepatic TB may present with abdominal pain and jaundice, while miliary hepatic TB may present with acute respiratory symptoms (cough, sputum production).</p><p>Presence of jaundice usually suggests biliary involvement. Isolated biliary tuberculosis is uncommon; manifestations include tubercular biliary stricture, obstruction of the biliary tract by enlarged lymph nodes compressing the biliary system, or, rarely, gallbladder involvement (which is usually identified as an incidental histologic finding in cholecystectomy pathology specimens) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/31,32\" class=\"abstract_t\">31,32</a>].</p><p>Elevated liver function tests (LFTs) may reflect the site of disease; involvement of the liver parenchyma may be reflected by elevated transaminases, while involvement of the porta or biliary ducts may be reflected by elevated alkaline phosphatase and gamma-glutamyl transferase (GGT). Mild hyperbilirubinemia has been reported in miliary and local hepatic TB [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H3576294548\"><span class=\"h2\">Other forms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Uncommon forms of abdominal TB include involvement of the esophagus (0.3 percent of abdominal TB), stomach (rare), duodenum (1 percent of abdominal TB), pancreas (rare), and spleen (rare) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1,33\" class=\"abstract_t\">1,33</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H262727290\"><span class=\"h2\">Clinical approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of abdominal tuberculosis should be suspected in patients with relevant clinical manifestations (fever, weight loss, abdominal pain <span class=\"nowrap\">and/or</span> distension, ascites, hepatomegaly, diarrhea, abdominal mass, abnormal liver function tests) as well as relevant epidemiologic factors (history of prior TB infection or disease, known or possible TB exposure, <span class=\"nowrap\">and/or</span> past or present residence in or travel to an area where TB is endemic).</p><p>Patients with concomitant clinical or radiographic findings suggestive of pulmonary involvement should also undergo diagnostic evaluation for pulmonary TB; this is discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-complications-of-pulmonary-tuberculosis\" class=\"medical medical_review\">&quot;Clinical manifestations and complications of pulmonary tuberculosis&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a>.)</p><p>The diagnosis of abdominal TB may be definitively established by demonstration of <em>M. tuberculosis</em> in peritoneal fluid (in the setting of ascites) or a biopsy specimen of an involved site (such as peritoneum, intestine, or liver) or via mycobacterial culture <span class=\"nowrap\">and/or</span> nucleic acid amplification test (NAAT) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30,34\" class=\"abstract_t\">30,34</a>]. In the United States, there is no approved NAAT for abdominal fluid or tissue; a positive validated NAA test strongly supports a diagnosis of TB. Histopathology (presence of caseating granulomas) is suggestive of tuberculosis but is not pathognomonic.</p><p>Patients with suspected abdominal TB should undergo radiographic imaging; computed tomography (CT) is preferred if feasible since it allows evaluation for involvement of the liver and other organs as well as presence of ascites, peritoneal involvement, and lymphadenopathy [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/35-37\" class=\"abstract_t\">35-37</a>].</p><p>Patients with ascites should undergo paracentesis. The fluid should be sent for routine tests (cell count and differential, albumin and protein concentration, Gram stain) as well as adenosine deaminase (ADA) level, acid-fast bacilli (AFB) smear, mycobacterial culture, and NAAT for <em>M. tuberculosis</em>. Patients with tuberculous peritonitis (in the absence of underlying cirrhosis) typically have lymphocytic ascites with serum-ascites albumin gradient (SAAG) &lt;1.1 <span class=\"nowrap\">g/dL</span>. An elevated ascites ADA level (30 to 39 international <span class=\"nowrap\">units/L)</span> is useful to support a diagnosis of TB in noncirrhotic patients but does not establish it with certainty. Patients with nondiagnostic ascites analysis should undergo peritoneal biopsy.</p><p>In the absence of ascites, biopsy should be pursued; the choice of biopsy site should be guided by the scope of anatomic involvement demonstrated on radiographic imaging. The approach to obtaining biopsy specimens should be tailored to individual circumstances, including the dominant site of involvement and associated risks and benefits. As examples, in the setting of intestinal involvement, endoscopic biopsies should be obtained; in the setting of isolated hepatic involvement, a liver biopsy should be pursued. All diagnostic specimens should be sent for histopathology, mycobacterial culture, and drug susceptibility testing.</p><p>In general, a diagnostic ascites analysis may be used to establish a diagnosis of abdominal TB in immunocompetent patients. However, in immunocompromised patients, the likelihood that more than one condition may be present is increased. Therefore, such patients may warrant collection of diagnostic specimens from each site of disease; the approach should be tailored to individual circumstances with assessment of risks and benefits.</p><p>It may not be possible to establish a definitive diagnosis of abdominal TB. Patients with probable abdominal TB include those with nondiagnostic mycobacterial culture and NAAT results but elevated ascitic fluid ADA <span class=\"nowrap\">and/or</span> consistent findings in histology, with exclusion of other items in the differential diagnosis.</p><p>Patients with known or suspected TB warrant testing for HIV infection. (See <a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute and early HIV infection: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H356317879\"><span class=\"h2\">Diagnostic tools</span></p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Radiographic imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Computed tomography is the most helpful imaging modality to evaluate for abdominal tuberculosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/38-40\" class=\"abstract_t\">38-40</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CT imaging in the setting of intestinal TB most commonly demonstrates concentric mural thickening in the ileocecal region, with or without proximal intestinal dilatation (<a href=\"image.htm?imageKey=ID%2F83833\" class=\"graphic graphic_diagnosticimage graphicRef83833 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F114924\" class=\"graphic graphic_diagnosticimage graphicRef114924 \">image 2</a> and <a href=\"image.htm?imageKey=ID%2F114925\" class=\"graphic graphic_diagnosticimage graphicRef114925 \">image 3</a> and <a href=\"image.htm?imageKey=ID%2F114926\" class=\"graphic graphic_diagnosticimage graphicRef114926 \">image 4</a>) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"abstract_t\">1</a>]. Occasionally, asymmetric thickening of the medial cecal wall is seen. Lymphadenopathy with hypodense centers (representing caseous liquefaction) may be present in the adjacent mesentery.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CT imaging in the setting of peritoneal TB demonstrates ascites, lymph nodes, thickening of the mesentery and omentum, and thickening of the peritoneum [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/41\" class=\"abstract_t\">41</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CT imaging in the setting of hepatic TB depends on whether the patient has miliary hepatic TB or local hepatic TB. CT imaging in the setting of miliary disease demonstrates multiple low-density micronodules dispersed throughout the liver; it may also demonstrate hepatomegaly without intrahepatic lesions or abdominal lymphadenopathy with peripheral lymph node enhancement <span class=\"nowrap\">and/or</span> calcifications [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30,42\" class=\"abstract_t\">30,42</a>]. CT imaging in the setting of local hepatic TB appears as a large solitary nodule or two to three low-density nodules with calcification and peripheral enhancement.</p><p/><p>Ultrasound is useful for detecting lymphadenopathy, ascites, peritoneal thickening, omental thickening, and bowel wall thickening [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>Small bowel follow-through or barium enema may demonstrate mucosal ulcerations and strictures, a deformed cecum, <span class=\"nowrap\">and/or</span> an incompetent ileocecal valve (<a href=\"image.htm?imageKey=RADIOL%2F85512\" class=\"graphic graphic_diagnosticimage graphicRef85512 \">image 5</a>) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Plain radiography may demonstrate air fluid levels with dilated small bowel levels (suggestive of intestinal obstruction) or hepatic calcifications [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H2978640207\"><span class=\"h3\">Ascitic fluid analysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with ascites should undergo paracentesis. The fluid should be sent for routine tests (cell count and differential, albumin and protein concentration, Gram stain) as well as ADA level, AFB smear, mycobacterial culture, and NAAT for <em>M. tuberculosis</em>. Patients with tuberculous peritonitis (in the absence of underlying cirrhosis) typically have lymphocytic ascites with SAAG &lt;1.1 <span class=\"nowrap\">g/dL</span>.</p><p>Most patients with tuberculous peritonitis have straw-colored ascites with leukocyte count of 150 to 4000 <span class=\"nowrap\">cells/mm<sup>3</sup>,</span> with a relative lymphocytic pleocytosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/11,24\" class=\"abstract_t\">11,24</a>]. Patients on peritoneal dialysis with tuberculous peritonitis may have a neutrophilic response [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/43,44\" class=\"abstract_t\">43,44</a>]. (See <a href=\"topic.htm?path=evaluation-of-adults-with-ascites\" class=\"medical medical_review\">&quot;Evaluation of adults with ascites&quot;</a>.)</p><p>The protein content of the ascitic fluid is usually &gt;3.0 <span class=\"nowrap\">g/dL</span> in the setting of tuberculous peritonitis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/18,45\" class=\"abstract_t\">18,45</a>]. The cell count is 150 to 4000 <span class=\"nowrap\">cells/mcL</span> and consists predominantly of lymphocytes [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2\" class=\"abstract_t\">2</a>]. Patients with tuberculous peritonitis (in the absence of underlying cirrhosis) typically have SAAG &lt;1.1 <span class=\"nowrap\">g/dL;</span> patients with underlying cirrhosis have SAAG &ge;1.1 [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/17,46,47\" class=\"abstract_t\">17,46,47</a>]. (See <a href=\"topic.htm?path=evaluation-of-adults-with-ascites\" class=\"medical medical_review\">&quot;Evaluation of adults with ascites&quot;</a>.)</p><p>The sensitivity of AFB smear and mycobacterial culture ascites fluid is low (less than 2 percent and less than 20 percent, respectively); broth culture results may be available in 2 to 3 weeks, and solid-phase culture results require several weeks [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2,24,48\" class=\"abstract_t\">2,24,48</a>]. The yield of mycobacterial culture may be increased (up to 83 percent) if 1 L of ascitic fluid (concentrated by centrifugation) is cultured [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/49\" class=\"abstract_t\">49</a>].</p><p>The utility of ascitic fluid NAAT or polymerase chain reaction (PCR) for diagnosis of tuberculous TB peritonitis has not been well established. One review including 11 cases of abdominal tuberculosis noted a positive PCR for <em>M. tuberculosis</em> of the ascitic fluid in all cases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/50\" class=\"abstract_t\">50</a>].</p><p>Measurement of ascites fluid ADA level is a useful tool for evaluation of patients with suspected TB peritonitis; it is most reliable in the absence of cirrhosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/51-54\" class=\"abstract_t\">51-54</a>]. An elevated ascites ADA level (30 to 39 international <span class=\"nowrap\">units/L)</span> is useful to support a diagnosis of TB in noncirrhotic patients but does not establish it with certainty. One meta-analysis of 12 studies including 264 patients found that ADA levels had high sensitivity and specificity (100 and 97 percent, respectively) using cut-off values from 36 to 40 international <span class=\"nowrap\">units/L;</span> the optimal cut-off value was 39 international <span class=\"nowrap\">units/L</span> [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/53\" class=\"abstract_t\">53</a>]. The sensitivity of ascites fluid ADA in patients with cirrhosis is approximately 30 percent, likely due to poor humoral and T cell&ndash;mediated response [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/47,55\" class=\"abstract_t\">47,55</a>]. In such cases, it may be a helpful supportive diagnostic tool if lower thresholds are used (21 to 30 international <span class=\"nowrap\">units/L)</span> [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1,56\" class=\"abstract_t\">1,56</a>].</p><p>Measurement of peritoneal fluid interferon-gamma concentration may be a useful tool for diagnosis of tuberculous peritonitis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/52,57-59\" class=\"abstract_t\">52,57-59</a>]. However, this test does not have a role in routine evaluation of suspected tuberculous peritonitis and has not been approved by the US Food and Drug Administration for this purpose.</p><p class=\"headingAnchor\" id=\"H658201713\"><span class=\"h3\">Obtaining biopsy specimens</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tools for obtaining biopsy specimens include laparoscopy, endoscopy (upper or lower), and radiographic-guided interventions. The approach to obtaining biopsy specimens should be tailored to individual circumstances, including the dominant site of involvement and associated risks and benefits. If ascitic fluid analysis is nondiagnostic, a peritoneal biopsy should be performed via laparoscopy. In the setting of intestinal involvement, endoscopic biopsies should be obtained; in the setting of isolated hepatic involvement, a liver biopsy should be pursued.</p><p class=\"headingAnchor\" id=\"H4006380808\"><span class=\"h4\">Peritoneal biopsy &ndash; Laparoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laparoscopy is useful for visualization of the peritoneum and peritoneal biopsy [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/10,18,19,24,48,50,60,61\" class=\"abstract_t\">10,18,19,24,48,50,60,61</a>]. In one systematic review including 402 patients, the sensitivity and specificity of laparoscopic examination in making the diagnosis of peritoneal TB was 93 and 98 percent, respectively [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/17\" class=\"abstract_t\">17</a>]. In another study including 38 patients with peritoneal TB, laparoscopic biopsy enabled a histologic diagnosis in 82 percent of cases; visual diagnosis was accurate in 95 percent of cases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Laparoscopic findings in the setting of tuberculous peritonitis include [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/19,50\" class=\"abstract_t\">19,50</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thickened peritoneum with yellowish-white lesions, with or without adhesions</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thickened peritoneum, with or without adhesions</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fibroadhesive pattern</p><p/><p>Other findings include enlarged lymph nodes, &quot;violin-string&quot; fibrinous strands, and omental thickening.</p><p>Blind peritoneal biopsies have a low success rate and have been associated with complications including death [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/62,63\" class=\"abstract_t\">62,63</a>].</p><p class=\"headingAnchor\" id=\"H2612234193\"><span class=\"h4\">Intestinal biopsy &ndash; Endoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Colonoscopy with biopsy is useful to obtain material for histology and culture [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/64-69\" class=\"abstract_t\">64-69</a>]. Biopsy is also useful for investigation of the diseases that comprise the differential diagnosis of TB enteritis. (See <a href=\"#H2548792619\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>Endoscopic findings of intestinal TB may include ulcers, strictures, nodules, pseudopolyps, fibrous bands, fistulas, <span class=\"nowrap\">and/or</span> deformed ileocecal valve (<a href=\"image.htm?imageKey=ID%2F114942\" class=\"graphic graphic_diagnosticimage graphicRef114942 \">image 6</a> and <a href=\"image.htm?imageKey=ID%2F114943\" class=\"graphic graphic_diagnosticimage graphicRef114943 \">image 7</a>) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/70\" class=\"abstract_t\">70</a>].</p><p>Forms of intestinal lesions include ulcerative and hypertrophic; these forms can coexist [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1,2,24,71\" class=\"abstract_t\">1,2,24,71</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The ulcerative presentation commonly affects the ileum and jejunum; it is characterized by single or multiple transverse ulcers that form strictures during the healing process and may perforate, bleed, or form fistulas [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/71\" class=\"abstract_t\">71</a>]. Ulcers due to TB tend to be circumferential (<a href=\"image.htm?imageKey=ID%2F83831\" class=\"graphic graphic_picture graphicRef83831 \">picture 1</a>) and are usually surrounded by inflamed mucosa.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The hypertrophic presentation commonly affects the ileocecal region and causes obstruction or presents as a mass. Ileocecal valve involvement usually includes both side's valve, leading to incompetence. A patulous valve with surrounding heaped-up folds or a destroyed valve with a fish mouth opening may be observed (<a href=\"image.htm?imageKey=ID%2F83832\" class=\"graphic graphic_picture graphicRef83832 \">picture 2</a>).</p><p/><p>Deep endoscopic biopsies should be taken from ulcers and their margins. TB granulomas are often submucosal, whereas granulomas due to Crohn disease are typically mucosal (though submucosal granulomas may also be seen) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/72\" class=\"abstract_t\">72</a>].</p><p>Endoscopic ultrasound may be used to pursue fine-needle aspiration biopsy of the peritoneum [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/73,74\" class=\"abstract_t\">73,74</a>].</p><p class=\"headingAnchor\" id=\"H1380206085\"><span class=\"h4\">Liver biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Liver biopsy with mycobacterial culture is the most specific diagnostic test for hepatic tuberculosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"abstract_t\">30</a>]. Liver biopsy provides microbiologic studies (including culture and drug susceptibility testing as well as nucleic acid amplification testing where available) as well as histopathologic examination (including staining for AFB).</p><p class=\"headingAnchor\" id=\"H3303330306\"><span class=\"h3\">Evaluating biopsy specimens</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Biopsy specimens should be sent for microbiology evaluation (including AFB smear, mycobacterial culture <span class=\"nowrap\">and/or</span> PCR) as well as histopathology evaluation.</p><p>The sensitivity of AFB smear and mycobacterial culture for biopsy specimens is low (less than 50 percent) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30,75\" class=\"abstract_t\">30,75</a>]. PCR is more sensitive and specific for diagnosis of TB than AFB smear or mycobacterial culture, and often PCR results are available sooner [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/29,76\" class=\"abstract_t\">29,76</a>]. The utility of PCR varies depending on the tissue type; sensitivity and specificity are high for peritoneal fluid and pancreatic and hepatic tissue, but intestinal tissue may be associated with false-positive PCR results. As an example, in one series including 43 liver biopsies with granulomas, PCR had sensitivity and specificity of 53 and 96 percent, respectively [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/75\" class=\"abstract_t\">75</a>]. Thus far, no commercial NAA tests (including Xpert <span class=\"nowrap\">MTB/RIF)</span> are approved in the United States for use with non&ndash;respiratory tract secretions.</p><p>Histologic evidence of caseating (necrotizing) granulomas had a median sensitivity of 68 percent among hepatic TB case series. Presence of caseating granulomas is suggestive of tuberculosis but is not pathognomonic; the finding may support a diagnosis of TB in the setting of other relevant clinical and epidemiologic factors [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Caseation granulomas and positive acid-fast stain are observed in less than 33 percent of cases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/65,70\" class=\"abstract_t\">65,70</a>]. Some histologic features that help differentiate TB enteritis from other etiologies include confluent granulomas, granulomas &gt;400 micrometers in diameter, more than five granulomas in biopsies from one segment, and granulomas located in the submucosa or granulation tissue [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1,77\" class=\"abstract_t\">1,77</a>].</p><p class=\"headingAnchor\" id=\"H2369941873\"><span class=\"h3\">Additional tools</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A positive <a href=\"topic.htm?path=tuberculin-skin-test-drug-information\" class=\"drug drug_general\">tuberculin skin test</a> or interferon-gamma release assay may be observed in patients with abdominal TB but is of limited value because these assays do not differentiate between active disease and latent infection [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/12,24\" class=\"abstract_t\">12,24</a>]. (See <a href=\"topic.htm?path=use-of-interferon-gamma-release-assays-for-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">&quot;Use of interferon-gamma release assays for diagnosis of latent tuberculosis infection (tuberculosis screening) in adults&quot;</a> and <a href=\"topic.htm?path=approach-to-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">&quot;Approach to diagnosis of latent tuberculosis infection (tuberculosis screening) in adults&quot;</a>.)</p><p>Stool PCR may be a useful adjunctive diagnostic tool for diagnosis of intestinal tuberculosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/78,79\" class=\"abstract_t\">78,79</a>].</p><p class=\"headingAnchor\" id=\"H2548792619\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of abdominal TB includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Crohn disease &ndash; There can be marked overlap between the features of Crohn disease (CD) and intestinal tuberculosis, making the differentiation between the two conditions difficult. Distinguishing between these entities is important because use of immunosuppressive drugs for a misdiagnosis of CD may be associated with clinical deterioration in patents with TB. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-crohn-disease-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis and prognosis of Crohn disease in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\">A combination of clinical, radiographic, endoscopic, laboratory, and biopsy findings are used to distinguish between them, as summarized in the table (<a href=\"image.htm?imageKey=ID%2F85948\" class=\"graphic graphic_table graphicRef85948 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/40,72,78,80-87\" class=\"abstract_t\">40,72,78,80-87</a>]. Additional considerations include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The presence of ascites may help to distinguish tuberculous enteritis from CD, since ascites is uncommon in CD.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In tuberculous enteritis, ileocecal valve involvement usually includes both sides of the valve, leading to incompetence (which is not typically observed in CD).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In the setting of TB, granulomas associated with TB tend to be submucosal, large, and confluent, often with caseation necrosis [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"abstract_t\">1</a>]. In the setting of CD, in contrast, granulomas are typically mucosal, infrequent, small, nonconfluent, and noncaseating.</p><p/><p class=\"bulletIndent1\">Definitive differentiation between intestinal TB and Crohn disease may not be possible; in such cases, a therapeutic trial with antituberculous therapy may be warranted [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/88\" class=\"abstract_t\">88</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>End-stage liver disease with ascites and spontaneous bacterial peritonitis &ndash; The presentation of spontaneous bacterial peritonitis is more acute than tuberculous peritonitis; the diagnosis may be established by examination of ascitic fluid (neutrophil count &gt;250 or positive Gram stain or culture). (See <a href=\"topic.htm?path=spontaneous-bacterial-peritonitis-in-adults-clinical-manifestations\" class=\"medical medical_review\">&quot;Spontaneous bacterial peritonitis in adults: Clinical manifestations&quot;</a> and <a href=\"topic.htm?path=spontaneous-bacterial-peritonitis-in-adults-diagnosis\" class=\"medical medical_review\">&quot;Spontaneous bacterial peritonitis in adults: Diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy &ndash; Malignancy may be associated with ascites, peritoneal involvement, <span class=\"nowrap\">and/or</span> liver lesions; it may be distinguished from abdominal TB via abdominal imaging, evaluation of ascites fluid for cytology, and biopsy for culture and histopathology. Malignant ascites is frequently a bloody exudate [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/4\" class=\"abstract_t\">4</a>]. Serum CA-125 concentrations can be elevated in the setting of ascites due to peritoneal TB, ovarian cancer, and other entities, so it cannot be used to distinguish between these diseases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/89\" class=\"abstract_t\">89</a>]. (See <a href=\"topic.htm?path=malignancy-related-ascites\" class=\"medical medical_review\">&quot;Malignancy-related ascites&quot;</a> and <a href=\"topic.htm?path=serum-biomarkers-for-evaluation-of-an-adnexal-mass-for-epithelial-carcinoma-of-the-ovary-fallopian-tube-or-peritoneum#H695605\" class=\"medical medical_review\">&quot;Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneum&quot;, section on 'CA 125'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphoma &ndash; Lymphoma may present with abdominal pain and weight loss with radiographic findings demonstrating abdominal lymphadenopathy. Lymph node biopsy for culture and histopathology evaluation is the most useful tool to distinguish between lymphoma and TB. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of non-Hodgkin lymphoma&quot;</a>.)</p><p/><p>Presence of granuloma on histopathology may reflect other conditions besides TB:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of caseating (necrotizing) granulomas includes fungal infection such as histoplasmosis and <em>Cryptococcus</em>. (See <a href=\"topic.htm?path=diagnosis-and-treatment-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">&quot;Diagnosis and treatment of pulmonary histoplasmosis&quot;</a> and <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of noncaseating granulomas includes sarcoidosis, rheumatoid pleuritis, and berylliosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;</a> and <a href=\"topic.htm?path=overview-of-lung-disease-associated-with-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Overview of lung disease associated with rheumatoid arthritis&quot;</a> and <a href=\"topic.htm?path=chronic-beryllium-disease-berylliosis\" class=\"medical medical_review\">&quot;Chronic beryllium disease (berylliosis)&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H2811972735\"><span class=\"h2\">Clinical approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with abdominal TB should be treated with antituberculous therapy. In addition, surgery is warranted for patients with complications such as perforation, abscess, fistula, bleeding, <span class=\"nowrap\">and/or</span> high-grade obstruction.</p><p>It may not be possible to establish a definitive diagnosis of abdominal TB. For situations in which there is a high index of suspicion based on clinical, epidemiologic, and diagnostic findings (such as elevated ascitic fluid adenosine deaminase [ADA] <span class=\"nowrap\">and/or</span> consistent findings in histology, with nondiagnostic mycobacterial culture and nucleic acid amplification test [NAAT] results), an empiric trial of antituberculous therapy is reasonable [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/25,64-66,68,90\" class=\"abstract_t\">25,64-66,68,90</a>]. (See <a href=\"#H262727290\" class=\"local\">'Clinical approach'</a> above.)</p><p class=\"headingAnchor\" id=\"H3958510411\"><span class=\"h2\">Antituberculous therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, the approach to antituberculous therapy for abdominal tuberculosis (TB) is the same as that for pulmonary TB [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/91-93\" class=\"abstract_t\">91-93</a>]. (See <a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">&quot;Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy&quot;</a> and <a href=\"topic.htm?path=treatment-of-drug-resistant-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Treatment of drug-resistant pulmonary tuberculosis in adults&quot;</a>.)</p><p>Fever usually resolves within one week of commencing antituberculous therapy. Patients with ascites have improvement within a few weeks of initiating treatment in 90 percent of cases [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/94\" class=\"abstract_t\">94</a>]. Patients with tuberculous enteritis generally demonstrate clinical improvement within two weeks on empiric therapy [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/93,95\" class=\"abstract_t\">93,95</a>]. In one study, colonoscopic follow-up after two to three months of anti-TB therapy showed complete healing of active ulcers and erosions [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/96\" class=\"abstract_t\">96</a>].</p><p>However, healing in the setting of antituberculous therapy can also result in worsening of strictures due to scar tissue formation. Patients who develop obstruction may warrant surgical intervention. In one series including 106 patients with stricturing intestinal TB, resolution of stricture following antituberculous therapy occurred in only 25 percent of patients [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/97\" class=\"abstract_t\">97</a>]. Stricture resolution occurred most frequently in the distal ileal and ileocecal region, followed by proximal small intestine and colon (36, 20, and 5 percent, respectively).</p><p>In the absence of clinical response to antituberculous therapy within two weeks, surgical exploration may be warranted to evaluate for alternative diagnoses such as Crohn disease, lymphoma, or malignancy [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H2738809358\"><span class=\"h2\">Surgery and other interventions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Surgery is warranted for patients with complications such as perforation, abscess, fistula, bleeding, <span class=\"nowrap\">and/or</span> high-grade obstruction [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/12,25,34\" class=\"abstract_t\">12,25,34</a>]. Patients with biliary obstruction due to stricture may require biliary reconstruction.</p><p>Intestinal obstruction is the most common complication; patients with multiple <span class=\"nowrap\">and/or</span> long strictures are less likely to respond to antituberculous therapy [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/28\" class=\"abstract_t\">28</a>]. In addition, obstruction may be exacerbated during antituberculous therapy due to healing by cicatrization [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=overview-of-management-of-mechanical-small-bowel-obstruction-in-adults\" class=\"medical medical_review\">&quot;Overview of management of mechanical small bowel obstruction in adults&quot;</a>.)</p><p>The surgical resection should be conservative; in some cases, multiple strictures of the small bowel may be amenable to strictureplasty to avoid major resection [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/34\" class=\"abstract_t\">34</a>]. Bypass surgery for obstructing lesions should be avoided because of complications related to blind loop syndrome.</p><p>An alternative approach to management of ileal stricture is colonoscopic balloon dilatation; this technique may be useful for management of symptomatic short ileal strictures [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/98\" class=\"abstract_t\">98</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mortality ranges from 8 to 50 percent in various series. Advanced age, delay in initiating therapy, and underlying cirrhosis have been associated with higher mortality rates [<a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/9-11,99\" class=\"abstract_t\">9-11,99</a>].</p><p class=\"headingAnchor\" id=\"H3825368733\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-diagnosis-and-treatment-of-tuberculosis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Diagnosis and treatment of tuberculosis&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-portal-hypertension-and-ascites\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Portal hypertension and ascites&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7875348\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal tuberculosis (TB) can present with involvement of any of the following sites: peritoneum, esophagus, stomach, intestinal tract, hepatobiliary tree, pancreas, perianal area, and lymph nodes. The most common forms of disease include involvement of the peritoneum, intestine, <span class=\"nowrap\">and/or</span> liver. Clinical manifestations of abdominal TB depend on the form of disease and may include fever, weight loss, abdominal pain <span class=\"nowrap\">and/or</span> distension, ascites, hepatomegaly, diarrhea, abdominal mass, and abnormal liver function tests. (See <a href=\"#H4048459905\" class=\"local\">'Forms of disease'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of abdominal TB should be suspected in patients with relevant clinical manifestations as well as relevant epidemiologic factors (history of prior TB infection or disease, known or possible TB exposure, <span class=\"nowrap\">and/or</span> past or present residence in or travel to an area where TB is endemic). (See <a href=\"#H3\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of abdominal TB may be definitively established by demonstration of <em>Mycobacterium tuberculosis</em> in peritoneal fluid (in the setting of ascites) or a biopsy specimen of an involved site (such as peritoneum, intestine, or liver) or via mycobacterial culture <span class=\"nowrap\">and/or</span> nucleic acid amplification test (NAAT). (See <a href=\"#H262727290\" class=\"local\">'Clinical approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with suspected abdominal TB should undergo radiographic imaging; computed tomography (CT) is preferred if feasible since it allows evaluation for involvement of the liver and other organs as well as presence of ascites, peritoneal involvement, and lymphadenopathy. (See <a href=\"#H6\" class=\"local\">'Radiographic imaging'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with ascites should undergo paracentesis. The fluid should be sent for routine tests (cell count and differential, albumin and protein concentration, Gram stain) as well as adenosine deaminase (ADA) level, acid-fast bacilli (AFB) smear, mycobacterial culture, and NAAT for <em>M. tuberculosis</em>. Patients with tuberculous peritonitis (in the absence of underlying cirrhosis) typically have lymphocytic ascites with serum-ascites albumin gradient (SAAG) &lt;1.1 <span class=\"nowrap\">g/dL</span>. An elevated ascites ADA level (30 to 39 international <span class=\"nowrap\">units/L)</span> is useful to support a diagnosis of TB in noncirrhotic patients but does not establish it with certainty. Patients with nondiagnostic ascites analysis should undergo peritoneal biopsy via laparoscopy. (See <a href=\"#H2978640207\" class=\"local\">'Ascitic fluid analysis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the absence of ascites, biopsy should be pursued; the choice of biopsy site should be guided by the scope of anatomic involvement demonstrated on radiographic imaging. The approach to obtaining biopsy specimens should be tailored to individual circumstances, including the dominant site of involvement and associated risks and benefits. As examples, in the setting of intestinal involvement, endoscopic biopsies should be obtained; in the setting of isolated hepatic involvement, a liver biopsy should be pursued. (See <a href=\"#H658201713\" class=\"local\">'Obtaining biopsy specimens'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with abdominal TB should be treated with antituberculous therapy. In addition, surgery is warranted for patients with complications such as perforation, abscess, fistula, bleeding, <span class=\"nowrap\">and/or</span> high-grade obstruction. In general, the approach to antituberculous therapy for abdominal TB is the same as that for pulmonary TB. Healing in the setting of antituberculous therapy can result in worsening of strictures due to scar tissue formation; patients who develop obstruction may warrant surgical intervention. (See <a href=\"#H11\" class=\"local\">'Management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>It may not be possible to establish a definitive diagnosis of abdominal TB. For situations in which there is a high index of suspicion based on clinical, epidemiologic, and diagnostic findings (such as elevated ascitic fluid ADA <span class=\"nowrap\">and/or</span> consistent findings in histology, with nondiagnostic mycobacterial culture and NAAT results), an empiric trial of antituberculous therapy is reasonable. (See <a href=\"#H2811972735\" class=\"local\">'Clinical approach'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/1\" class=\"nounderline abstract_t\">Rathi P, Gambhire P. Abdominal Tuberculosis. J Assoc Physicians India 2016; 64:38.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/2\" class=\"nounderline abstract_t\">Debi U, Ravisankar V, Prasad KK, et al. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol 2014; 20:14831.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/3\" class=\"nounderline abstract_t\">Evans RP, Mourad MM, Dvorkin L, Bramhall SR. Hepatic and Intra-abdominal Tuberculosis: 2016 Update. Curr Infect Dis Rep 2016; 18:45.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/4\" class=\"nounderline abstract_t\">Vaid U, Kane GC. Tuberculous Peritonitis. Microbiol Spectr 2017; 5.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/5\" class=\"nounderline abstract_t\">Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004; 120:316.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/6\" class=\"nounderline abstract_t\">Mehta JB, Dutt A, Harvill L, Mathews KM. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 1991; 99:1134.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/7\" class=\"nounderline abstract_t\">Braun MM, Byers RH, Heyward WL, et al. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 1990; 150:1913.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/8\" class=\"nounderline abstract_t\">Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/9\" class=\"nounderline abstract_t\">Aguado JM, Pons F, Casafont F, et al. Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. J Clin Gastroenterol 1990; 12:550.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/10\" class=\"nounderline abstract_t\">Chow KM, Chow VC, Hung LC, et al. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples. Clin Infect Dis 2002; 35:409.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/11\" class=\"nounderline abstract_t\">al-Quorain AA, Facharzt, Satti MB, et al. Abdominal tuberculosis in Saudi Arabia: a clinicopathological study of 65 cases. Am J Gastroenterol 1993; 88:75.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/12\" class=\"nounderline abstract_t\">Kapoor VK. Abdominal tuberculosis. Postgrad Med J 1998; 74:459.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/13\" class=\"nounderline abstract_t\">Tang LC, Cho HK, Wong Taam VC. Atypical presentation of female genital tract tuberculosis. Eur J Obstet Gynecol Reprod Biol 1984; 17:355.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/14\" class=\"nounderline abstract_t\">Tanrikulu AC, Aldemir M, Gurkan F, et al. Clinical review of tuberculous peritonitis in 39 patients in Diyarbakir, Turkey. J Gastroenterol Hepatol 2005; 20:906.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/15\" class=\"nounderline abstract_t\">Lisehora GB, Peters CC, Lee YT, Barcia PJ. Tuberculous peritonitis--do not miss it. Dis Colon Rectum 1996; 39:394.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/16\" class=\"nounderline abstract_t\">Gitt S, Haddad F, Levenson S. Tuberculous peritonitis: an overlooked diagnosis. Hosp Pract (Off Ed) 1992; 27:224.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/17\" class=\"nounderline abstract_t\">Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis--presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 2005; 22:685.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/18\" class=\"nounderline abstract_t\">Manohar A, Simjee AE, Haffejee AA, Pettengell KE. Symptoms and investigative findings in 145 patients with tuberculous peritonitis diagnosed by peritoneoscopy and biopsy over a five year period. Gut 1990; 31:1130.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/19\" class=\"nounderline abstract_t\">Bhargava DK, Shriniwas, Chopra P, et al. Peritoneal tuberculosis: laparoscopic patterns and its diagnostic accuracy. Am J Gastroenterol 1992; 87:109.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/20\" class=\"nounderline abstract_t\">Das P, Shukla HS. Clinical diagnosis of abdominal tuberculosis. Br J Surg 1976; 63:941.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/21\" class=\"nounderline abstract_t\">Bhansali SK. Abdominal tuberculosis. Experiences with 300 cases. Am J Gastroenterol 1977; 67:324.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/22\" class=\"nounderline abstract_t\">Tandon RK, Sarin SK, Bose SL, et al. A clinico-radiological reappraisal of intestinal tuberculosis--changing profile? Gastroenterol Jpn 1986; 21:17.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/23\" class=\"nounderline abstract_t\">Singh V, Jain AK, Agrawal AK, et al. Clinicopathological profile of abdominal tuberculosis. Br J Clin Pract 1995; 49:22.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/24\" class=\"nounderline abstract_t\">Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993; 88:989.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/25\" class=\"nounderline abstract_t\">Horvath KD, Whelan RL. Intestinal tuberculosis: return of an old disease. Am J Gastroenterol 1998; 93:692.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/26\" class=\"nounderline abstract_t\">Petrosyan M, Mason RJ. Tuberculous enteritis presenting as small-bowel obstruction. Clin Gastroenterol Hepatol 2006; 4:xxiii.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/27\" class=\"nounderline abstract_t\">Garc&iacute;a-D&iacute;az RA, Ruiz-G&oacute;mez JL, Rodr&iacute;guez-Sanjuan JC, et al. Perforation of the colon caused by intestinal tuberculosis. Dis Colon Rectum 2006; 49:927; author reply 927.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/28\" class=\"nounderline abstract_t\">Ha HK, Ko GY, Yu ES, et al. Intestinal tuberculosis with abdominal complications: radiologic and pathologic features. Abdom Imaging 1999; 24:32.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/29\" class=\"nounderline abstract_t\">Donoghue HD, Holton J. Intestinal tuberculosis. Curr Opin Infect Dis 2009; 22:490.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/30\" class=\"nounderline abstract_t\">Hickey AJ, Gounder L, Moosa MY, Drain PK. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis 2015; 15:209.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/31\" class=\"nounderline abstract_t\">Amarapurkar DN, Patel ND, Amarapurkar AD. Hepatobiliary tuberculosis in western India. Indian J Pathol Microbiol 2008; 51:175.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/32\" class=\"nounderline abstract_t\">Xu XF, Yu RS, Qiu LL, et al. Gallbladder tuberculosis: CT findings with histopathologic correlation. Korean J Radiol 2011; 12:196.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/33\" class=\"nounderline abstract_t\">Sharma V, Rana SS, Kumar A, Bhasin DK. Pancreatic tuberculosis. J Gastroenterol Hepatol 2016; 31:310.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/34\" class=\"nounderline abstract_t\">Aston NO. Abdominal tuberculosis. World J Surg 1997; 21:492.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/35\" class=\"nounderline abstract_t\">Demirkazik FB, Akhan O, Ozmen MN, Akata D. US and CT findings in the diagnosis of tuberculous peritonitis. Acta Radiol 1996; 37:517.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/36\" class=\"nounderline abstract_t\">Akhan O, Pringot J. Imaging of abdominal tuberculosis. Eur Radiol 2002; 12:312.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/37\" class=\"nounderline abstract_t\">V&aacute;zquez Mu&ntilde;oz E, G&oacute;mez-Cerezo J, Atienza Saura M, V&aacute;zquez Rodriguez JJ. Computed tomography findings of peritoneal tuberculosis: systematic review of seven patients diagnosed in 6 years (1996-2001). Clin Imaging 2004; 28:340.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/38\" class=\"nounderline abstract_t\">Balthazar EJ, Gordon R, Hulnick D. Ileocecal tuberculosis: CT and radiologic evaluation. AJR Am J Roentgenol 1990; 154:499.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/39\" class=\"nounderline abstract_t\">Suri S, Gupta S, Suri R. Computed tomography in abdominal tuberculosis. Br J Radiol 1999; 72:92.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/40\" class=\"nounderline abstract_t\">Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009; 104:1003.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/41\" class=\"nounderline abstract_t\">Guirat A, Koubaa M, Mzali R, et al. Peritoneal tuberculosis. Clin Res Hepatol Gastroenterol 2011; 35:60.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/42\" class=\"nounderline abstract_t\">Yu RS, Zhang SZ, Wu JJ, Li RF. Imaging diagnosis of 12 patients with hepatic tuberculosis. World J Gastroenterol 2004; 10:1639.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/43\" class=\"nounderline abstract_t\">Quantrill SJ, Woodhead MA, Bell CE, et al. Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2001; 16:1024.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/44\" class=\"nounderline abstract_t\">Gupta N, Prakash KC. Asymptomatic tuberculous peritonitis in a CAPD patient. Perit Dial Int 2001; 21:416.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/45\" class=\"nounderline abstract_t\">Kim NJ, Choo EJ, Kwak YG, et al. Tuberculous peritonitis in cirrhotic patients: comparison of spontaneous bacterial peritonitis caused by Escherichia coli with tuberculous peritonitis. Scand J Infect Dis 2009; 41:852.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/46\" class=\"nounderline abstract_t\">Poyrazoglu OK, Timurkaan M, Yalniz M, et al. Clinical review of 23 patients with tuberculous peritonitis: presenting features and diagnosis. J Dig Dis 2008; 9:170.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/47\" class=\"nounderline abstract_t\">Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology 1996; 24:1408.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/48\" class=\"nounderline abstract_t\">Chow KM, Chow VC, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg 2003; 185:567.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/49\" class=\"nounderline abstract_t\">Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med 1969; 281:1091.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/50\" class=\"nounderline abstract_t\">Uzunkoy A, Harma M, Harma M. Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol 2004; 10:3647.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/51\" class=\"nounderline abstract_t\">Shen YC, Wang T, Chen L, et al. Diagnostic accuracy of adenosine deaminase for tuberculous peritonitis: a meta-analysis. Arch Med Sci 2013; 9:601.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/52\" class=\"nounderline abstract_t\">Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis 2017; 64:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/53\" class=\"nounderline abstract_t\">Riquelme A, Calvo M, Salech F, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol 2006; 40:705.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/54\" class=\"nounderline abstract_t\">Tao L, Ning HJ, Nie HM, et al. Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites: a meta-analysis. Diagn Microbiol Infect Dis 2014; 79:102.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/55\" class=\"nounderline abstract_t\">Huang HJ, Yang J, Huang YC, et al. Diagnostic feature of tuberculous peritonitis in patients with cirrhosis: A matched case-control study. Exp Ther Med 2014; 7:1028.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/56\" class=\"nounderline abstract_t\">Liao YJ, Wu CY, Lee SW, et al. Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol 2012; 18:5260.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/57\" class=\"nounderline abstract_t\">Su SB, Qin SY, Guo XY, et al. Assessment by meta-analysis of interferon-gamma for the diagnosis of tuberculous peritonitis. World J Gastroenterol 2013; 19:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/58\" class=\"nounderline abstract_t\">Sharma SK, Tahir M, Mohan A, et al. Diagnostic accuracy of ascitic fluid IFN-gamma and adenosine deaminase assays in the diagnosis of tuberculous ascites. J Interferon Cytokine Res 2006; 26:484.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/59\" class=\"nounderline abstract_t\">Ribera E, Mart&iacute;nez V&aacute;squez JM, Oca&ntilde;a I, et al. Diagnostic value of ascites gamma interferon levels in tuberculous peritonitis. Comparison with adenosine deaminase activity. Tubercle 1991; 72:193.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/60\" class=\"nounderline abstract_t\">Inadomi JM, Kapur S, Kinkhabwala M, Cello JP. The laparoscopic evaluation of ascites. Gastrointest Endosc Clin N Am 2001; 11:79.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/61\" class=\"nounderline abstract_t\">Chahed J, Mekki M, Mansour A, et al. Contribution of laparoscopy in the abdominal tuberculosis diagnosis: retrospective study of about 11 cases. Pediatr Surg Int 2010; 26:413.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/62\" class=\"nounderline abstract_t\">Shukla HS, Bhatia S, Naitrani YP, et al. Peritoneal biopsy for diagnosis of abdominal tuberculosis. Postgrad Med J 1982; 58:226.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/63\" class=\"nounderline abstract_t\">Bastani B, Shariatzadeh MR, Dehdashti F. Tuberculous peritonitis--report of 30 cases and review of the literature. Q J Med 1985; 56:549.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/64\" class=\"nounderline abstract_t\">Bhargava DK, Kushwaha AK, Dasarathy S, et al. Endoscopic diagnosis of segmental colonic tuberculosis. Gastrointest Endosc 1992; 38:571.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/65\" class=\"nounderline abstract_t\">Shah S, Thomas V, Mathan M, et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut 1992; 33:347.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/66\" class=\"nounderline abstract_t\">Misra SP, Misra V, Dwivedi M, Gupta SC. Colonic tuberculosis: clinical features, endoscopic appearance and management. J Gastroenterol Hepatol 1999; 14:723.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/67\" class=\"nounderline abstract_t\">Kalvaria I, Kottler RE, Marks IN. The role of colonoscopy in the diagnosis of tuberculosis. J Clin Gastroenterol 1988; 10:516.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/68\" class=\"nounderline abstract_t\">Singh V, Kumar P, Kamal J, et al. Clinicocolonoscopic profile of colonic tuberculosis. Am J Gastroenterol 1996; 91:565.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/69\" class=\"nounderline abstract_t\">Kim KM, Lee A, Choi KY, et al. Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy. Am J Gastroenterol 1998; 93:606.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/70\" class=\"nounderline abstract_t\">Alvares JF, Devarbhavi H, Makhija P, et al. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy 2005; 37:351.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/71\" class=\"nounderline abstract_t\">Figueroa D, Guzman N, Isache C. Tuberculous Enteritis: A Rare Complication of Miliary Tuberculosis. Case Rep Infect Dis 2016; 2016:6949834.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/72\" class=\"nounderline abstract_t\">Kirsch R, Pentecost M, Hall Pde M, et al. Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis. J Clin Pathol 2006; 59:840.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/73\" class=\"nounderline abstract_t\">Rana SS, Bhasin DK, Srinivasan R, Singh K. Endoscopic ultrasound-guided fine needle aspiration of peritoneal nodules in patients with ascites of unknown cause. Endoscopy 2011; 43:1010.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/74\" class=\"nounderline abstract_t\">Kocaman O, Danalio&#287;lu A, &#304;nce AT, et al. Diagnosis of tuberculous peritonitis using endoscopic ultrasound-guided fine-needle aspiration biopsy of the peritoneum. Turk J Gastroenterol 2013; 24:65.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/75\" class=\"nounderline abstract_t\">Diaz ML, Herrera T, Lopez-Vidal Y, et al. Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas. J Lab Clin Med 1996; 127:359.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/76\" class=\"nounderline abstract_t\">Anand BS, Schneider FE, El-Zaatari FA, et al. Diagnosis of intestinal tuberculosis by polymerase chain reaction on endoscopic biopsy specimens. Am J Gastroenterol 1994; 89:2248.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/77\" class=\"nounderline abstract_t\">Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol 2005; 20:688.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/78\" class=\"nounderline abstract_t\">Ramadass B, Chittaranjan S, Subramanian V, Ramakrishna BS. Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn's disease from intestinal tuberculosis. Indian J Gastroenterol 2010; 29:152.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/79\" class=\"nounderline abstract_t\">Kokuto H, Sasaki Y, Yoshimatsu S, et al. Detection of Mycobacterium tuberculosis (MTB) in Fecal Specimens From Adults Diagnosed With Pulmonary Tuberculosis Using the Xpert MTB/Rifampicin Test. Open Forum Infect Dis 2015; 2:ofv074.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/80\" class=\"nounderline abstract_t\">Kedia S, Sharma R, Sreenivas V, et al. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis. Intest Res 2017; 15:149.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/81\" class=\"nounderline abstract_t\">Pulimood AB, Ramakrishna BS, Kurian G, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 1999; 45:537.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/82\" class=\"nounderline abstract_t\">Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 2006; 38:592.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/83\" class=\"nounderline abstract_t\">Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol 2010; 105:642.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/84\" class=\"nounderline abstract_t\">Li X, Liu X, Zou Y, et al. Predictors of clinical and endoscopic findings in differentiating Crohn's disease from intestinal tuberculosis. Dig Dis Sci 2011; 56:188.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/85\" class=\"nounderline abstract_t\">Pulimood AB, Amarapurkar DN, Ghoshal U, et al. Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol 2011; 17:433.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/86\" class=\"nounderline abstract_t\">Yu H, Liu Y, Wang Y, et al. Clinical, endoscopic and histological differentiations between Crohn's disease and intestinal tuberculosis. Digestion 2012; 85:202.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/87\" class=\"nounderline abstract_t\">Bae JH, Park SH, Ye BD, et al. Development and Validation of a Novel Prediction Model for Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis. Inflamm Bowel Dis 2017; 23:1614.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/88\" class=\"nounderline abstract_t\">Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther 2017; 45:27.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/89\" class=\"nounderline abstract_t\">Koc S, Beydilli G, Tulunay G, et al. Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases. Gynecol Oncol 2006; 103:565.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/90\" class=\"nounderline abstract_t\">Wagner TE, Huseby ES, Huseby JS. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor. Am J Med 2002; 112:67.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/91\" class=\"nounderline abstract_t\">Jullien S, Jain S, Ryan H, Ahuja V. Six-month therapy for abdominal tuberculosis. Cochrane Database Syst Rev 2016; 11:CD012163.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/92\" class=\"nounderline abstract_t\">Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent Directly Observed Therapy for Abdominal Tuberculosis: A Multicenter Randomized Controlled Trial Comparing 6 Months Versus 9 Months of Therapy. Clin Infect Dis 2015; 61:750.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/93\" class=\"nounderline abstract_t\">Tony J, Sunilkumar K, Thomas V. Randomized controlled trial of DOTS versus conventional regime for treatment of ileocecal and colonic tuberculosis. Indian J Gastroenterol 2008; 27:19.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/94\" class=\"nounderline abstract_t\">Demir K, Okten A, Kaymakoglu S, et al. Tuberculous peritonitis--reports of 26 cases, detailing diagnostic and therapeutic problems. Eur J Gastroenterol Hepatol 2001; 13:581.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/95\" class=\"nounderline abstract_t\">Giouleme O, Paschos P, Katsaros M, et al. Intestinal tuberculosis: a diagnostic challenge--case report and review of the literature. Eur J Gastroenterol Hepatol 2011; 23:1074.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/96\" class=\"nounderline abstract_t\">Park YS, Jun DW, Kim SH, et al. Colonoscopy evaluation after short-term anti-tuberculosis treatment in nonspecific ulcers on the ileocecal area. World J Gastroenterol 2008; 14:5051.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/97\" class=\"nounderline abstract_t\">Aggarwal P, Kedia S, Sharma R, et al. Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy. Dig Dis Sci 2017; 62:2847.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/98\" class=\"nounderline abstract_t\">Bhasin DK, Sharma BC, Dhavan S, et al. Endoscopic balloon dilation of ileal stricture due to tuberculosis. Endoscopy 1998; 30:S44.</a></li><li><a href=\"https://www.uptodate.com/contents/abdominal-tuberculosis/abstract/99\" class=\"nounderline abstract_t\">Wang HK, Hsueh PR, Hung CC, et al. Tuberculous peritonitis: analysis of 35 cases. J Microbiol Immunol Infect 1998; 31:113.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1238 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H7875348\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2572768201\" id=\"outline-link-H2572768201\">RISK FACTORS</a></li><li><a href=\"#H4048459905\" id=\"outline-link-H4048459905\">FORMS OF DISEASE</a><ul><li><a href=\"#H2513640203\" id=\"outline-link-H2513640203\">Peritoneal tuberculosis</a></li><li><a href=\"#H3439164440\" id=\"outline-link-H3439164440\">Intestinal tuberculosis</a></li><li><a href=\"#H631605469\" id=\"outline-link-H631605469\">Hepatic tuberculosis</a></li><li><a href=\"#H3576294548\" id=\"outline-link-H3576294548\">Other forms</a></li></ul></li><li><a href=\"#H3\" id=\"outline-link-H3\">DIAGNOSIS</a><ul><li><a href=\"#H262727290\" id=\"outline-link-H262727290\">Clinical approach</a></li><li><a href=\"#H356317879\" id=\"outline-link-H356317879\">Diagnostic tools</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Radiographic imaging</a></li><li><a href=\"#H2978640207\" id=\"outline-link-H2978640207\">- Ascitic fluid analysis</a></li><li><a href=\"#H658201713\" id=\"outline-link-H658201713\">- Obtaining biopsy specimens</a><ul><li><a href=\"#H4006380808\" id=\"outline-link-H4006380808\">Peritoneal biopsy &ndash; Laparoscopy</a></li><li><a href=\"#H2612234193\" id=\"outline-link-H2612234193\">Intestinal biopsy &ndash; Endoscopy</a></li><li><a href=\"#H1380206085\" id=\"outline-link-H1380206085\">Liver biopsy</a></li></ul></li><li><a href=\"#H3303330306\" id=\"outline-link-H3303330306\">- Evaluating biopsy specimens</a></li><li><a href=\"#H2369941873\" id=\"outline-link-H2369941873\">- Additional tools</a></li></ul></li></ul></li><li><a href=\"#H2548792619\" id=\"outline-link-H2548792619\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">MANAGEMENT</a><ul><li><a href=\"#H2811972735\" id=\"outline-link-H2811972735\">Clinical approach</a></li><li><a href=\"#H3958510411\" id=\"outline-link-H3958510411\">Antituberculous therapy</a></li><li><a href=\"#H2738809358\" id=\"outline-link-H2738809358\">Surgery and other interventions</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">PROGNOSIS</a></li><li><a href=\"#H3825368733\" id=\"outline-link-H3825368733\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H7875348\" id=\"outline-link-H7875348\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/1238|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83833\" class=\"graphic graphic_diagnosticimage\">- CT tuberculous enteritis</a></li><li><a href=\"image.htm?imageKey=ID/114924\" class=\"graphic graphic_diagnosticimage\">- Intestinal TB &ndash; CT enteroclysis I</a></li><li><a href=\"image.htm?imageKey=ID/114925\" class=\"graphic graphic_diagnosticimage\">- Intestinal TB &ndash; CT enteroclysis II</a></li><li><a href=\"image.htm?imageKey=ID/114926\" class=\"graphic graphic_diagnosticimage\">- Intestinal TB &ndash; CT abdomen</a></li><li><a href=\"image.htm?imageKey=RADIOL/85512\" class=\"graphic graphic_diagnosticimage\">- TB enteritis - Barium enema</a></li><li><a href=\"image.htm?imageKey=ID/114942\" class=\"graphic graphic_diagnosticimage\">- Intestinal tuberculosis - Endoscopy 1</a></li><li><a href=\"image.htm?imageKey=ID/114943\" class=\"graphic graphic_diagnosticimage\">- Intestinal tuberculosis - Endoscopy 2</a></li></ul></li><li><div id=\"ID/1238|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83831\" class=\"graphic graphic_picture\">- Ascending colon TB enteritis</a></li><li><a href=\"image.htm?imageKey=ID/83832\" class=\"graphic graphic_picture\">- Ileocecal tuberculous enteritis</a></li></ul></li><li><div id=\"ID/1238|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/85948\" class=\"graphic graphic_table\">- Distinguishing Crohn versus intestinal TB</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute and early HIV infection: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">Approach to diagnosis of latent tuberculosis infection (tuberculosis screening) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-beryllium-disease-berylliosis\" class=\"medical medical_review\">Chronic beryllium disease (berylliosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-complications-of-pulmonary-tuberculosis\" class=\"medical medical_review\">Clinical manifestations and complications of pulmonary tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of pulmonary sarcoidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-crohn-disease-in-adults\" class=\"medical medical_review\">Clinical manifestations, diagnosis and prognosis of Crohn disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">Clinical presentation and diagnosis of non-Hodgkin lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">Cryptococcus neoformans infection outside the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">Diagnosis and treatment of pulmonary histoplasmosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">Diagnosis of pulmonary tuberculosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-tuberculosis\" class=\"medical medical_review\">Epidemiology of tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-adults-with-ascites\" class=\"medical medical_review\">Evaluation of adults with ascites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=malignancy-related-ascites\" class=\"medical medical_review\">Malignancy-related ascites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-lung-disease-associated-with-rheumatoid-arthritis\" class=\"medical medical_review\">Overview of lung disease associated with rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-management-of-mechanical-small-bowel-obstruction-in-adults\" class=\"medical medical_review\">Overview of management of mechanical small bowel obstruction in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serum-biomarkers-for-evaluation-of-an-adnexal-mass-for-epithelial-carcinoma-of-the-ovary-fallopian-tube-or-peritoneum\" class=\"medical medical_review\">Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneum</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-diagnosis-and-treatment-of-tuberculosis\" class=\"medical medical_society_guidelines\">Society guideline links: Diagnosis and treatment of tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-portal-hypertension-and-ascites\" class=\"medical medical_society_guidelines\">Society guideline links: Portal hypertension and ascites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=spontaneous-bacterial-peritonitis-in-adults-clinical-manifestations\" class=\"medical medical_review\">Spontaneous bacterial peritonitis in adults: Clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=spontaneous-bacterial-peritonitis-in-adults-diagnosis\" class=\"medical medical_review\">Spontaneous bacterial peritonitis in adults: Diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-drug-resistant-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">Treatment of drug-resistant pulmonary tuberculosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=use-of-interferon-gamma-release-assays-for-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">Use of interferon-gamma release assays for diagnosis of latent tuberculosis infection (tuberculosis screening) in adults</a></li></ul></div></div>","javascript":null}